rs28437296

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001458.5(FLNC):​c.8121T>C​(p.Ile2707Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00431 in 1,608,118 control chromosomes in the GnomAD database, including 158 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 48 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 110 hom. )

Consequence

FLNC
NM_001458.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -4.09

Publications

4 publications found
Variant links:
Genes affected
FLNC (HGNC:3756): (filamin C) This gene encodes one of three related filamin genes, specifically gamma filamin. These filamin proteins crosslink actin filaments into orthogonal networks in cortical cytoplasm and participate in the anchoring of membrane proteins for the actin cytoskeleton. Three functional domains exist in filamin: an N-terminal filamentous actin-binding domain, a C-terminal self-association domain, and a membrane glycoprotein-binding domain. Mutations in this gene are a cause of cardiopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2022]
FLNC-AS1 (HGNC:53474): (FLNC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 7-128858466-T-C is Benign according to our data. Variant chr7-128858466-T-C is described in ClinVar as Benign. ClinVar VariationId is 129101.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.09 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0158 (2396/151972) while in subpopulation AFR AF = 0.0471 (1946/41354). AF 95% confidence interval is 0.0453. There are 48 homozygotes in GnomAd4. There are 1132 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2396 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLNCNM_001458.5 linkc.8121T>C p.Ile2707Ile synonymous_variant Exon 48 of 48 ENST00000325888.13 NP_001449.3 Q14315-1Q59H94
FLNCNM_001127487.2 linkc.8022T>C p.Ile2674Ile synonymous_variant Exon 47 of 47 NP_001120959.1 Q14315-2Q59H94
FLNC-AS1NR_149055.1 linkn.102+4059A>G intron_variant Intron 1 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLNCENST00000325888.13 linkc.8121T>C p.Ile2707Ile synonymous_variant Exon 48 of 48 1 NM_001458.5 ENSP00000327145.8 Q14315-1

Frequencies

GnomAD3 genomes
AF:
0.0158
AC:
2392
AN:
151854
Hom.:
48
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0471
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00511
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0152
Gnomad SAS
AF:
0.0279
Gnomad FIN
AF:
0.000566
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.00933
AC:
2329
AN:
249500
AF XY:
0.00973
show subpopulations
Gnomad AFR exome
AF:
0.0483
Gnomad AMR exome
AF:
0.00255
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0120
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.00163
Gnomad OTH exome
AF:
0.00660
GnomAD4 exome
AF:
0.00312
AC:
4541
AN:
1456146
Hom.:
110
Cov.:
32
AF XY:
0.00368
AC XY:
2667
AN XY:
724240
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0278
AC:
896
AN:
32194
American (AMR)
AF:
0.00231
AC:
103
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26134
East Asian (EAS)
AF:
0.0166
AC:
656
AN:
39548
South Asian (SAS)
AF:
0.0210
AC:
1779
AN:
84568
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53414
Middle Eastern (MID)
AF:
0.00245
AC:
14
AN:
5710
European-Non Finnish (NFE)
AF:
0.000740
AC:
821
AN:
1109880
Other (OTH)
AF:
0.00443
AC:
266
AN:
60040
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.347
Heterozygous variant carriers
0
237
473
710
946
1183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0158
AC:
2396
AN:
151972
Hom.:
48
Cov.:
32
AF XY:
0.0152
AC XY:
1132
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.0471
AC:
1946
AN:
41354
American (AMR)
AF:
0.00511
AC:
78
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0153
AC:
79
AN:
5172
South Asian (SAS)
AF:
0.0279
AC:
134
AN:
4800
European-Finnish (FIN)
AF:
0.000566
AC:
6
AN:
10600
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00190
AC:
129
AN:
67978
Other (OTH)
AF:
0.0109
AC:
23
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.420
Heterozygous variant carriers
0
106
213
319
426
532
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00586
Hom.:
7
Bravo
AF:
0.0170
EpiCase
AF:
0.00202
EpiControl
AF:
0.00213

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Feb 14, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 19, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 26, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.97
DANN
Benign
0.46
PhyloP100
-4.1
Mutation Taster
=80/20
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28437296; hg19: chr7-128498520; COSMIC: COSV99972436; COSMIC: COSV99972436; API